- Report
- August 2023
- 51 Pages
United States
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Australia
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Japan
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Turkey
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Italy
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
China
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Switzerland
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Argentina
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Brazil
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Israel
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
Colombia
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
India
From €570EUR$600USD£479GBP
- Report
- August 2023
- 51 Pages
South Africa
From €570EUR$600USD£479GBP
- Report
- August 2022
- 327 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- November 2021
- 802 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- June 2022
- 297 Pages
Global
From €3285EUR$3,456USD£2,760GBP
- Book
- September 2022
- 176 Pages

The Guide RNA (gRNA) market is a subset of the genomics industry that focuses on the development and production of gRNA molecules. gRNA molecules are used in a variety of applications, including gene editing, gene regulation, and gene expression. gRNA molecules are composed of a guide sequence, which is complementary to a specific target sequence in the genome, and a scaffold sequence, which provides stability and specificity to the gRNA molecule.
The gRNA market is driven by the increasing demand for gene editing and gene regulation technologies, as well as the growing need for more efficient and cost-effective gene expression tools. Additionally, the development of new gRNA technologies, such as CRISPR-Cas9, has further increased the demand for gRNA molecules.
Some of the major companies in the gRNA market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, New England Biolabs, and OriGene Technologies. Show Less Read more